For once I actually agree with you and everything is lining for a substantial IPIX price run. What started out as one RBL investigation into BRILACIDIN has now expanded into the recently completed PHASE 2 trial and a expanding multitude of Universities and researchers testing BRILACIDIN SI *426*. What started out simply as GMU testing BRILACIDINs activity against the Covid virus has now expanded to various research teams around the country showing extremely positive results against Retroviruses, Alpaviruses, Bunyaviruses and yesterday's surprise now includes the Adenovirus family. IPIX and the BRILACIDIN research results are on a very impressive run. It's time for the stock price to mirror all that positivity.